ERY-TAB
- Product NDC
- 55289-217
- 11-digit product format
- 552890217
- Labeler code
- 55289
- Product ID
- 55289-217_e6eb5cc4-cb16-39cd-e053-2995a90aa603
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA062298
- Marketing category
- ANDA
- Marketing start
- 2011-04-18
- Marketing end
- 0000-00-00
- Substance
- ERYTHROMYCIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Erythromycin | ACTIVE INGREDIENT | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| Erythromycin | ACTIVE MOIETY | 63937KV33D | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| Ammonia | INACTIVE INGREDIENT | 5138Q19F1X | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| crospovidone | INACTIVE INGREDIENT | 68401960MK | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| hydroxypropyl cellulose | INACTIVE INGREDIENT | RFW2ET671P | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| hypromellose phthalate (24% PHTHALATE, 55 CST) | INACTIVE INGREDIENT | 87Y6436BKR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| povidone | INACTIVE INGREDIENT | FZ989GH94E | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| sorbitan monooleate | INACTIVE INGREDIENT | 06XEA2VD56 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55289-217 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 17 | Legacy NDC | 20241011_3acbc324-9a11-4e48-b5ad-b4cc3b38dd48.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55289-217-28 | 55289021728 | 28 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-28) | 2011-12-21 | 0000-00-00 | No | No | Current |
| 55289-217-40 | 55289021740 | 40 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (55289-217-40) | 2011-12-21 | 0000-00-00 | No | No | Current |